This protocol describes the monitoring of nanoparticle treated human hepatocarcinoma cells (HepG2) for apoptosis, as part of the in vitro NCL preclinical characterization cascade. The protocol utilizes a fluorescent method to determine the degree of caspase-3 activation.
- NCL_Method_GTA-6.pdf(PDF | 704 KB)
Cite this work
Researchers should cite this work as follows: